Posts Tagged ‘Sarepta Therapeutics Inc. (SRPT)’

Steven Cohen

Breaking Down Steve Cohen’s Four Latest Moves in Sarepta Therapeutics (SRPT), Smith & Wesson (SWHC), More

Steve Cohen‘s Point72 Asset Management has upped its stake in two companies and added two new holdings to its equity portfolio, according to four......(read more)
Nektar Therapeutics (NASDAQ:NKTR)

Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Is Nektar Therapeutics (NASDAQ:NKTR) a good investment? Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment......(read more)
Acorda Therapeutics Inc (NASDAQ:ACOR)

Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It

To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age. Although there are In excess of 8,000 hedge funds......(read more)
Santarus, Inc. (NASDAQ:SNTS)

Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

What should a smart Santarus, Inc. (NASDAQ:SNTS) investor do? In the financial world, there are a multitude of gauges investors can use to watch publicly......(read more)
Sarepta Therapeutics Inc

Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)

Is it smart to be bullish on Sarepta Therapeutics Inc (NASDAQ:SRPT)? If you were to ask many of your fellow readers, hedge funds are seen as overrated......(read more)
Sarepta Therapeutics Inc

Sarepta Therapeutics Inc (SRPT), GlaxoSmithKline plc (ADR) (GSK): An Edge Emerges in the Race to Treat Muscular Dystrophy

In a previous article, I speculated on the race to develop a Duchenne muscular dystrophy, or DMD, drug and who might win it. It seems now that Sarepta......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): Could This DMD Treatment Become a Blockbuster Drug?

Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene — the largest gene on the X......(read more)
ChemoCentryx Inc (NASDAQ:CCXI)

ChemoCentryx Inc (CCXI), GlaxoSmithKline plc (ADR) (GSK): Horrendous Health-Care Stocks This Week

While many investors worried about the Nasdaq’s three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn’t have......(read more)
VIVUS, Inc. (NASDAQ:VVUS)

What Hedge Funds Think About VIVUS, Inc. (VVUS)

Are you curious what the richest investors think about VIVUS, Inc. (NASDAQ:VVUS)? In the 21st century investor’s toolkit, there are dozens of metrics......(read more)
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Alexion Pharmaceuticals, Inc. (ALXN), Sarepta Therapeutics Inc (SRPT), Regeneron Pharmaceuticals Inc (REGN): Is There Any Remaining Value in This Industry Leader?

At some point, a company reaches a level of maximum valuation. It doesn’t mean the company becomes bad, but rather all upside is priced in and future......(read more)
Questcor Pharmaceuticals Inc (NASDAQ:QCOR)

Sarepta Therapeutics Inc (SRPT), ISIS Pharmaceuticals, Inc. (ISIS): Is Questcor Pharmaceuticals Inc (QCOR) Still Undervalued?

It has been approximately a year since the Citron Research report about Questcor Pharmaceuticals Inc (NASDAQ:QCOR) came out, which caused the stock to......(read more)
Sarepta Therapeutics Inc

GlaxoSmithKline plc (ADR) (GSK), Gilead Sciences, Inc. (GILD): Did Sarepta Therapeutics Inc (SRPT) Just Knock Out Its DMD Competitor?

Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa  for a moment......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): The Good and Bad of a Competitor’s Failure

On the surface, GlaxoSmithKline plc (ADR) (NYSE:GSK)‘s release of phase 2 data on drisapersen looks like good news for Sarepta Therapeutics Inc......(read more)
Mylan Inc. (NASDAQ:MYL)

Mylan Inc. (MYL), YY Inc (ADR) (YY): Stocks Near 52-Week Highs Worth Selling

Even with the broad-based S&P 500 retracing for three straight days amid worries that the Federal Reserve may begin paring back its monthly bond-buying......(read more)
Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Regeneron Pharmaceuticals Inc (REGN), Pharmacyclics, Inc. (PCYC): Is There Pipeline Potential in These Biotech Stocks?

It is not uncommon for a biotechnology company to be valued solely on the potential of one drug. For many small and midcap biotechs, the potential of......(read more)
GT Advanced Technologies Inc (NASDAQ:GTAT)

GT Advanced Technologies Inc (GTAT), Outerwall Inc (OUTR): The Nasdaq’s 5 Most Hated Stocks

Economic problems and worries? We’ll have none of those here, says the Nasdaq Composite, which soared to a fresh 12-year high on this week’......(read more)
Questcor Pharmaceuticals Inc (NASDAQ:QCOR)

Questcor Pharmaceuticals Inc (QCOR), Sarepta Therapeutics Inc (SRPT): Here’s What This $7 Billion Contrarian Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)
AcelRx Pharmaceuticals Inc

AcelRx Pharmaceuticals Inc (ACRX): Long-Term Growth With Biotech Innovators

The global biotechnology industry is expected to reach $320 billion by 2015, up from $232 billion in 2012. Improving healthcare infrastructure and focus......(read more)
Sequenom, Inc. (NASDAQ:SQNM)

Sequenom, Inc. (SQNM), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week

This week’s list of the most horrendous health-care stocks is brought to you by the letter “S.” Just like on Sesame Street, all of the......(read more)
Array Biopharma Inc (NASDAQ:ARRY)

Array Biopharma Inc (ARRY), InterMune Inc (ITMN): Three Humongous Health-Care Stocks This Week

After extensive research, number-crunching, sorting, and filtering, the results are in. Here are your three most humongous performers in the world of......(read more)
Sarepta Therapeutics Inc

Sarepta Therapeutics Inc (SRPT) Moves Ahead With Seeking Eteplirsen Approval: Hip, Hip, Uh-Oh?

Investors wondered for months if Sarepta Therapeutics Inc (NASDAQ:SRPT) would pursue accelerated approval for Duchenne muscular dystrophy, or DMD, drug......(read more)
Prosensa

Prosensa Holding BV (RNA), WebMD Health Corp. (WBMD): Three Humongous Health-Care Stocks This Week

If you thought the fireworks ended after the Fourth of July celebrations last week, think again. Plenty of pops and bangs were heard in the world of health......(read more)
Sarepta Therapeutics Inc

Sarepta Therapeutics Inc (SRPT): Is The DMD Market Becoming Too Crowded?

A year ago, AVI BioPharma underwent a process from being an $85 million biotechnology company to a $1.3 billion company called Sarepta Therapeutics Inc......(read more)
YRC Worldwide, Inc. (NASDAQ:YRCW)

YRC Worldwide, Inc. (YRCW), Sarepta Therapeutics Inc (SRPT), Christopher & Banks Corporation (CBK): Russell Rebalance Could Push These Stocks Even Higher!

Last year, these three stocks weren’t even on the radar of most retail investors, but have since returned incredible gains. Now, another catalyst could......(read more)
Sarepta Therapeutics Inc

Sarepta Therapeutics Inc (SRPT), National-Oilwell Varco, Inc. (NOV): Here’s What This $17 Billion Hedge Fund Company Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)
Hess Corp. (NYSE:HES)

Insiders Have Bought Hess Corp. (HES), Questcor (QCOR), and More

One implication of the principle of diversification is that company insiders- who, in a way, are already “invested” in the company as it is a source......(read more)
Sarepta Therapeutics Inc

Sarepta Therapeutics Inc (SRPT), VIVUS, Inc. (VVUS): The Week’s Biotech Winner and Loser

What’s the best way to choose the biotech winner and loser of the past week? The easiest route would involve the companies with the biggest share price......(read more)
Sarepta Therapeutics Inc

Three Views for Sarepta Therapeutics Inc (SRPT) on Prosensa’s IPO

Sarepta Therapeutics Inc (NASDAQ:SRPT) won’t be the only stock choice for a biotech focusing on Duchenne muscular dystrophy, or DMD, much longer......(read more)
Clovis Oncology Inc (NASDAQ:CLVS)

Clovis Oncology Inc (CLVS), Sarepta Therapeutics Inc (SRPT): Three Healthcare Stocks to Keep an Eye On

The healthcare industry is slowly becoming what the pre-crash technology industry was of the early 2000′s. The emergence of new technologies......(read more)
MannKind Corporation (NASDAQ:MNKD)

MannKind Corporation (MNKD), Sarepta Therapeutics Inc (SRPT): Why You Shouldn’t Buy Stocks in Biotech

How can you double your investment literally overnight? Buy stocks of the right biotech companies. However, you can also cut your investment by half overnight......(read more)
Nektar Therapeutics (NASDAQ:NKTR)

Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?

Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds’ portfolio at the end of March. NKTR has experienced a decrease in support from the world......(read more)
GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Why You Should Care About This Diabetes Drug Saga

GlaxoSmithKline plc (ADR) (NYSE:GSK)‘s diabetes drug Avandia causes heart issues. Or maybe it doesn’t. Either way, regulators figured the......(read more)
Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (JNJ), Sarepta Therapeutics Inc (SRPT), Edwards Lifesciences Corp (EW): 3 Health Care Investment Ideas for June

If you heeded the old adage to “sell in May and go away” this year, you’re probably second-guessing your decision now. The major indexes......(read more)

Santarus, Inc. (SNTS): Insiders Are Buying, Should You?

Santarus, Inc. (NASDAQ:SNTS) investors should pay attention to a decrease in hedge fund interest in recent months. If you’d ask most shareholders......(read more)

This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 19 hedge funds’ portfolio at the end of March. SRPT shareholders have witnessed an increase in enthusiasm......(read more)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Aegerion Pharmaceuticals, Inc. (AEGR): A $90 Price Target for This Biotech! How’s It Figured?

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) is currently trading higher by 13% after having its price target raised to $90 by Canaccord – which is......(read more)

Liberty Media Corp (LMCA), Sarepta Therapeutics Inc (SRPT): Here’s What This $42 Billion Hedge Fund Company Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Where to Invest for More Health-Care Exposure

You have plenty of choices of where to invest your portfolio. It’s hard to hit every sector — and do it well — but I think most investors......(read more)
MeadWestvaco Corp. (MWV)

MeadWestvaco Corp. (MWV), Brocade Communications Systems, Inc. (BRCD): What George Soros Has Been Buying

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a......(read more)
Keryx Biopharmaceuticals (NASDAQ:KERX)

Keryx Biopharmaceuticals (KERX), Dynavax Technologies Corporation (DVAX): Biotech Investing for Beginners

Huge fortunes are won and lost in the world of biotech nearly every week. For those new to this world, it can appear both alluring and scary. Biotech......(read more)

Sarepta Therapeutics Inc (SRPT): Sad Trombone?

The words of the great big-band leader Duke Ellington came to mind after hearing the first quarter results from Sarepta Therapeutics Inc (NASDAQ:SRPT......(read more)
Questcor Pharmaceuticals Inc (NASDAQ:QCOR)

Questcor Pharmaceuticals Inc (QCOR): Impressive Revenue Growth

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) has faced the affects of bad press more than once in the past. The stock lost more than half of its value last......(read more)

Edwards Lifesciences Corp (EW), Sarepta Therapeutics Inc (SRPT), Rigel Pharmaceuticals, Inc. (RIGL): April’s Unhealthiest Stocks

Leading health-care stocks have had a good start to the year, but all’s not healthy in the world of medicine. Several notable stocks from the sector......(read more)

Sarepta Therapeutics Inc (SRPT), Pharmacyclics, Inc. (PCYC): Are These Billion-Dollar Biotechs Overvalued?

Biotechs with market caps of a billion dollars or more are a dime a dozen. Well, actually, they’re more like $12 billion or more a dozen, but you......(read more)

Vertex Pharmaceuticals Incorporated (VRTX), MannKind Corporation (MNKD): Want to Invest in Biotech? Think Like a Venture Capitalist

They’re demanding. They take risks — but only calculated ones. And they ask lots of penetrating questions to understand as much as possible......(read more)

Nokia Corporation (ADR) (NOK), Freeport-McMoRan Copper & Gold Inc. (FCX) & Five of Last Week’s Biggest Losers

There’s never a shortage of losers in the stock market. Let’s take a closer look at five of this past week’s biggest sinkers. Company......(read more)

Allergan, Inc. (AGN), Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK) & The Week, Biotech

With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Kerr Neilson

Hedge Funds Are Selling ImmunoGen, Inc. (IMGN)

ImmunoGen, Inc. (NASDAQ:IMGN) investors should pay attention to a decrease in hedge fund interest recently. At the moment, there are dozens of methods......(read more)

Sarepta Therapeutics Inc (SRPT): FDA Says, “Call Me Maybe”

A lot has been written this week — at The Fool and elsewhere — about Sarepta Therapeutics Inc (NASDAQ:SRPT)‘ update on its meeting......(read more)

GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): Telecoms Disconnected as These Two Stocks Tumbled

So much for the big correction. Although the Dow Jones Industrial Average didn’t completely regain all the ground it lost the day before, the 157......(read more)
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!